BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7737043)

  • 1. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results.
    Spear RC; Bois FY
    Environ Health Perspect; 1994 Dec; 102 Suppl 11(Suppl 11):61-6. PubMed ID: 7737043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling benzene pharmacokinetics across three sets of animal data: parametric sensitivity and risk implications.
    Spear RC; Bois FY; Woodruff T; Auslander D; Parker J; Selvin S
    Risk Anal; 1991 Dec; 11(4):641-54. PubMed ID: 1780503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and parameterization of pharmacokinetic models: their impact on model predictions.
    Woodruff TJ; Bois FY; Auslander D; Spear RC
    Risk Anal; 1992 Jun; 12(2):189-201. PubMed ID: 1502372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically-based pharmacokinetic modeling of benzene in humans: a Bayesian approach.
    Yokley K; Tran HT; Pekari K; Rappaport S; Riihimaki V; Rothman N; Waidyanatha S; Schlosser PM
    Risk Anal; 2006 Aug; 26(4):925-43. PubMed ID: 16948686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of three physiologically based pharmacokinetic models of benzene disposition.
    Bois FY; Woodruff TJ; Spear RC
    Toxicol Appl Pharmacol; 1991 Aug; 110(1):79-88. PubMed ID: 1871774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization issues in physiological toxicokinetic modeling: a case study with benzene.
    Woodruff TJ; Bois FY
    Toxicol Lett; 1993 Aug; 69(2):181-96. PubMed ID: 8212060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmacokinetics and metabolism.
    Bois FY; Smith MT; Spear RC
    Toxicol Lett; 1991 May; 56(3):283-98. PubMed ID: 2035176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An analysis of exposure rate effects for benzene using a physiologically based pharmacokinetic model.
    Bois FY; Paxman DG
    Regul Toxicol Pharmacol; 1992 Apr; 15(2 Pt 1):122-36. PubMed ID: 1626064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessing benzene risks using internal doses and Monte-Carlo uncertainty analysis.
    Cox LA
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1413-29. PubMed ID: 9118928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing human variability in kinetics for exposures to multiple environmental chemicals: a physiologically based pharmacokinetic modeling case study with dichloromethane, benzene, toluene, ethylbenzene, and m-xylene.
    Valcke M; Haddad S
    J Toxicol Environ Health A; 2015; 78(7):409-31. PubMed ID: 25785556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of benzene.
    Travis CC; Quillen JL; Arms AD
    Toxicol Appl Pharmacol; 1990 Mar; 102(3):400-20. PubMed ID: 2315912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo metabolic interactions of benzene and toluene.
    Purcell KJ; Cason GH; Gargas ML; Andersen ME; Travis CC
    Toxicol Lett; 1990 Jul; 52(2):141-52. PubMed ID: 2377998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physiologically based pharmacokinetic modeling of benzene metabolism in mice through extrapolation from in vitro to in vivo.
    Cole CE; Tran HT; Schlosser PM
    J Toxicol Environ Health A; 2001 Mar; 62(6):439-65. PubMed ID: 11289318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-exposure to gasoline vapor decreases benzene metabolism in Fischer-344 rats.
    Travis CC; Fox MT; Simmons WM; Lyon BF
    Toxicol Lett; 1992 Sep; 62(2-3):231-40. PubMed ID: 1412508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
    Watanabe KH; Bois FY
    Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro studies of perchloroethylene metabolism for physiologically based pharmacokinetic modeling in rats, mice, and humans.
    Reitz RH; Gargas ML; Mendrala AL; Schumann AM
    Toxicol Appl Pharmacol; 1996 Feb; 136(2):289-306. PubMed ID: 8619237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicompartment liver-based pharmacokinetic model for benzene and its metabolites in mice.
    Manning CC; Schlosser PM; Tran HT
    Bull Math Biol; 2010 Apr; 72(3):507-40. PubMed ID: 20041354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population toxicokinetics of benzene.
    Bois FY; Jackson ET; Pekari K; Smith MT
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1405-11. PubMed ID: 9118927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite-based internal doses used in a risk assessment of benzene.
    Bailer AJ; Hoel DG
    Environ Health Perspect; 1989 Jul; 82():177-84. PubMed ID: 2792038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model parameter estimation and analysis: understanding parametric structure.
    Li H; Watanabe K; Auslander D; Spear RC
    Ann Biomed Eng; 1994; 22(1):97-111. PubMed ID: 8060031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.